URL details: sextonlab.com/in-vitro-evaluation-and-mitigation-of-niclosamides-liabilities-as-a-covid-19-treatment/
URL title:
In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment – Sexton Laboratory
URL paragraphs:
Niclosamide, an FDA-approved oral anthelmintic drug, has broad biological activity including anticancer, antibacterial, and antiviral properties. Niclosamide has also been identified as a potent inhibitor of SARS-CoV-2 infection in vitro, generating intere
URL last crawled:
2023-01-06
URL speed:
0.978 MB/s,
downloaded in 0.060 seconds
We found no external links pointing to this url.